Why Is BridgeBio Pharma, Inc. (BBIO) Stock Down Today?
Live update on BBIO's stock movement with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
BridgeBio Pharma, Inc. (BBIO)
Summary
BridgeBio Pharma, Inc. (BBIO) is trading down -1.70% at $82.66, reflecting a negative shift in investor sentiment today. The stock opened at $83.48 and has moved between $82.09 and $83.58 so far.
Trading volume is 1955091, which is 47% below its average, and the price action suggests selling interest.
Technically, BBIO is trading above its 50-day moving average of $70.18 and above its 200-day moving average of $69.48, indicating short-term and long-term strength.
Analyst sentiment is bullish. Meyka's AI assigns BBIO a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -3.80% in 1 month ($79.52), -0.08% in 1 year ($82.59), and +104.57% in 5 years ($169.10).
See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.
BBIO Technical Signals
Trading over 50-day moving average ($70.18)
Trading over 200-day moving average ($69.48)
Analyst Recommendations
Price Forecast
1 Month
$79.52
1 Year
$82.59
3 Years
$125.77
5 Years
$169.10
Is this change significant?
5-Day:-8.97%
1-Month:+21.56%
3-Month:+6.38%
What's next?
Next earnings date: 7/30/2025